Doctors Scientific Organica (DSO) manufactures and markets of range of products, including health & wellness foods, vitamins and supplements, including several weight loss products.
“This acquisition is a transformative event that will support Bonne Santé's objective of creating a highly diversified and vertically integrated global nutraceutical company,” stated A.J. Cervantes, Jr., the Chairman of Bonne Santé Group, in a press release. “Our vision at BSG is to develop and acquire multiple brands and sales channels for cross marketing goods and services. Our company will benefit by being able to deliver proprietary branded health & wellness products that are seeing extraordinary demand.”
“I am excited to join the team at Bonne Santé Group and become a major shareholder,” added Dr. Sasson Moulavi, the founder and principal of Doctors Scientific Organica. “I share the company's vison of building a high growth global nutraceutical company in the health & wellness sector and look forward to working with A.J. and the entire management team to accelerate DSO and Smart for Life's product line into additional markets in the United States and around the world.”
“Dr. Sass has created an extraordinary company and brand,” said Darren Minton, Bonne Santé Group's President. “Not only are several of their products currently being sold in major big box retailers with additional product lines ready for expansion, this acquisition further validates the concept of supporting shared management and market intelligence among our various facilities and healthy lifestyle categories.”
Bonne Santé Group, Inc. calls itself “an emerging growth global nutraceutical company” that is “executing a buy and build strategy with planned serial accretive acquisitions”.
In 2020, BSG and its subsidiary Bonne Santé Natural Manufacturing, Inc. entered into a strategic partnership with Twinlab to manufacture Twinlab’s products, with a focus on powders, capsules and tablets.
BSG also announced that concurrent with the DSO acquisition, it had completed an equity and debt financing that totaled $11 million, with four funds providing the equity financing and a commercial lender, Diamond Creek Capital, LLC, providing the senior secured debt.